top of page
LIQID Medical currently has two core devices under development. Each device has been designed to create the most clinically effective, cost-saving, and quality-of-life-improving solutions for severe and refractory glaucoma.
The OptiShunt fills a gap in the market for a highly effective glaucoma device which does not rely on the traditional subconjunctival drainage pathway.
The iFlow harnesses the traditional fluid drainage pathway, using innovative design to reduce surgical operating times, costs, and complications.
Zero bleb complications
No Mitomycin C required
Highly cost effective
Broad range of applications
A breakthrough in glaucoma implants
bottom of page